Analytical, Diagnostic and Therapeutic Techniques, and Equipment [E] » Diagnosis [E01] » Prognosis » Treatment Outcome » Sustained Virologic Response
Health Care [N] » Health Services Administration [N04] » Quality of Health Care » Outcome and Process Assessment, Health Care » Outcome Assessment, Health Care » Treatment Outcome » Sustained Virologic Response
Health Care [N] » Health Care Quality, Access, and Evaluation [N05] » Quality of Health Care » Health Care Evaluation Mechanisms » Outcome and Process Assessment, Health Care » Outcome Assessment, Health Care » Treatment Outcome » Sustained Virologic Response
Description
The continuous, long-term suppression of VIRAL LOAD, generally to undetectable levels, as the result of treatment with ANTIVIRAL AGENTS. MeSH
Hierarchy View
Phase 4 Indicated Drugs (1)
Other Experimental Indicated Drugs (4)
Hierarchy Tree View
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.